The Potential of N6-Methyladenine-Targeted Editing Tools in Cancer Treatment

Xinfei Wu

2025

Abstract

With the continuous development of bioengineering technology, the study of m6A has become one of the core fields of epitranscription, but the development of m6A editing tools is still the focus of today's research. Increased methylation levels of m6A are highly susceptible to the development of cancer or tumors. Therefore, this review aims to discuss the development of m6A-targeting tools in cancer therapy, and summarize the role of m6A in the delivery system, gene editing modification in oncolytic viruses, and the markers of m6A in breast and lung cancer, as well as its targeted editing tools. Based on the development of targeted tools and the analysis of the defects of m6A in cancer to the prospect of the future, the new direction and vitality brought by m6A research in cancer treatment are illustrated.

Paper Citation

in Harvard Style

Wu X. (2025). The Potential of N6-Methyladenine-Targeted Editing Tools in Cancer Treatment. In Proceedings of the 1st International Conference on Biomedical Engineering and Food Science - Volume 1: BEFS; ISBN 978-989-758-789-4, SciTePress, pages 357-361. DOI: 10.5220/0014493300004933

in Bibtex Style

@conference{befs25,
author={Xinfei Wu},
title={The Potential of N6-Methyladenine-Targeted Editing Tools in Cancer Treatment},
booktitle={Proceedings of the 1st International Conference on Biomedical Engineering and Food Science - Volume 1: BEFS},
year={2025},
pages={357-361},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0014493300004933},
isbn={978-989-758-789-4},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 1st International Conference on Biomedical Engineering and Food Science - Volume 1: BEFS
TI - The Potential of N6-Methyladenine-Targeted Editing Tools in Cancer Treatment
SN - 978-989-758-789-4
AU - Wu X.
PY - 2025
SP - 357
EP - 361
DO - 10.5220/0014493300004933
PB - SciTePress